[
  {
    "ts": "2025-08-07T19:29:19+00:00",
    "headline": "Alexandria Real Estate Equities, Inc. (ARE): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Alexandria Real Estate Equities, Inc. on Compounding Dividends’s Substack by TJ Terwilliger. In this article, we will summarize the bulls’ thesis on ARE. Alexandria Real Estate Equities, Inc.’s share was trading at $73.85 as of August 6th. ARE’s trailing and forward P/E were 150.89 and 16.69 respectively according to Yahoo […]",
    "url": "https://finance.yahoo.com/news/alexandria-real-estate-equities-inc-192919183.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8ad6ca6b-3f7c-3e87-8daa-0bdf165173bf",
      "content": {
        "id": "8ad6ca6b-3f7c-3e87-8daa-0bdf165173bf",
        "contentType": "STORY",
        "title": "Alexandria Real Estate Equities, Inc. (ARE): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Alexandria Real Estate Equities, Inc. on Compounding Dividends’s Substack by TJ Terwilliger. In this article, we will summarize the bulls’ thesis on ARE. Alexandria Real Estate Equities, Inc.’s share was trading at $73.85 as of August 6th. ARE’s trailing and forward P/E were 150.89 and 16.69 respectively according to Yahoo […]",
        "pubDate": "2025-08-07T19:29:19Z",
        "displayTime": "2025-08-07T19:29:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/6f1594a96e38dda21ac26bd03fd4d648",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jCikGV.lZjdWivgaC6mQBg--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/6f1594a96e38dda21ac26bd03fd4d648.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PXw6gUcuDR14PeJT31Lp9w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/6f1594a96e38dda21ac26bd03fd4d648.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/alexandria-real-estate-equities-inc-192919183.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/alexandria-real-estate-equities-inc-192919183.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ARE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "GOOGL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-07T19:17:04+00:00",
    "headline": "Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?",
    "summary": "With vaccine revenue crumbling and layoffs in full swing, is Moderna’s slimmed-down strategy a smart move or a red flag for investors?",
    "url": "https://www.barchart.com/story/news/33972262/moderna-is-cutting-10-000-jobs-as-its-business-erodes-how-should-you-play-mrna-stock-here",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "99a108eb-9dd4-322f-9c2c-f211f5abe0f4",
      "content": {
        "id": "99a108eb-9dd4-322f-9c2c-f211f5abe0f4",
        "contentType": "STORY",
        "title": "Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?",
        "description": "",
        "summary": "With vaccine revenue crumbling and layoffs in full swing, is Moderna’s slimmed-down strategy a smart move or a red flag for investors?",
        "pubDate": "2025-08-07T19:17:04Z",
        "displayTime": "2025-08-07T19:17:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/e07a98d38106a7710d2a8edf7a45e8c7",
          "originalWidth": 1000,
          "originalHeight": 647,
          "caption": "Moderna Inc meds-by Ascannio via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IjklA.ybT4OZ93REul1bBg--~B/aD02NDc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/e07a98d38106a7710d2a8edf7a45e8c7.cf.webp",
              "width": 1000,
              "height": 647,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YY1dIx.60ivNzIi74vtvbw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/e07a98d38106a7710d2a8edf7a45e8c7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/33972262/moderna-is-cutting-10-000-jobs-as-its-business-erodes-how-should-you-play-mrna-stock-here",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-cutting-10-000-jobs-191704556.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-07T14:16:00+00:00",
    "headline": "Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma",
    "summary": "The global influenza vaccine market is on a growth trajectory, driven by heightened awareness about vaccination's role in preventing contagious diseases like influenza. In light of recent pandemics, flu vaccination demand is surging, projected to climb from USD 8.96 billion in 2024 to USD 13.32 billion by 2030, at a CAGR of 7%. Rising geriatric populations, government support, and public health campaigns fuel this expansion. Dominant market segments include quadrivalent vaccines, inactivated typ",
    "url": "https://finance.yahoo.com/news/influenza-vaccine-market-research-report-141600698.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "50e3cd9f-9b74-331e-93fd-f1f39c3486ef",
      "content": {
        "id": "50e3cd9f-9b74-331e-93fd-f1f39c3486ef",
        "contentType": "STORY",
        "title": "Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma",
        "description": "",
        "summary": "The global influenza vaccine market is on a growth trajectory, driven by heightened awareness about vaccination's role in preventing contagious diseases like influenza. In light of recent pandemics, flu vaccination demand is surging, projected to climb from USD 8.96 billion in 2024 to USD 13.32 billion by 2030, at a CAGR of 7%. Rising geriatric populations, government support, and public health campaigns fuel this expansion. Dominant market segments include quadrivalent vaccines, inactivated typ",
        "pubDate": "2025-08-07T14:16:00Z",
        "displayTime": "2025-08-07T14:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/influenza-vaccine-market-research-report-141600698.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/influenza-vaccine-market-research-report-141600698.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "EBS"
            },
            {
              "symbol": "006280.KS"
            },
            {
              "symbol": "GSK.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-07T11:34:54+00:00",
    "headline": "RFK Jr’s mRNA funding halt signals “shift in US public health”",
    "summary": "The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.",
    "url": "https://www.pharmaceutical-technology.com/news/rfk-jr-mrna-funding-halt/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "c8850655-c9ba-3e92-8713-49b6c80f4874",
      "content": {
        "id": "c8850655-c9ba-3e92-8713-49b6c80f4874",
        "contentType": "STORY",
        "title": "RFK Jr’s mRNA funding halt signals “shift in US public health”",
        "description": "",
        "summary": "The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.",
        "pubDate": "2025-08-07T11:34:54Z",
        "displayTime": "2025-08-07T11:34:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/0497a9a81b24f4eab7122c9a272da590",
          "originalWidth": 1024,
          "originalHeight": 653,
          "caption": "RFK Jr has cancelled mRNA vaccine development projects worth $500m run by BARDA. Image credit: Jim Watson",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jvoNdjKgdBX_6dJfiCoaIg--~B/aD02NTM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/0497a9a81b24f4eab7122c9a272da590.cf.webp",
              "width": 1024,
              "height": 653,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R2tpJpYlhv2Ty1pFF2JkWQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/0497a9a81b24f4eab7122c9a272da590.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/rfk-jr-mrna-funding-halt/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rfk-jr-mrna-funding-halt-113454062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-07T08:31:00+00:00",
    "headline": "AI is already upending the corporate org chart as it flattens the distance between the C-suite and everyone else",
    "summary": "AI isn't just a new tool for the modern workplace; it's quietly reshaping how companies are organized.",
    "url": "https://finance.yahoo.com/news/ai-already-upending-corporate-org-083100729.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "2df42856-69c1-3b9a-96db-5755c01c1e3d",
      "content": {
        "id": "2df42856-69c1-3b9a-96db-5755c01c1e3d",
        "contentType": "STORY",
        "title": "AI is already upending the corporate org chart as it flattens the distance between the C-suite and everyone else",
        "description": "",
        "summary": "AI isn't just a new tool for the modern workplace; it's quietly reshaping how companies are organized.",
        "pubDate": "2025-08-07T08:31:00Z",
        "displayTime": "2025-08-07T08:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/33a92d1b46ecff43f605d029a92c0f06",
          "originalWidth": 2048,
          "originalHeight": 1365,
          "caption": "AI isn't just a new tool for the modern workplace; it's quietly reshaping how companies are organized.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t3.mapQYaPosNrQdSk.EzA--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/33a92d1b46ecff43f605d029a92c0f06.cf.webp",
              "width": 2048,
              "height": 1365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2nCJy3xDFnoVejAcx1Zi5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/33a92d1b46ecff43f605d029a92c0f06.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ai-already-upending-corporate-org-083100729.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ai-already-upending-corporate-org-083100729.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]